Skip to main content

Table 2 Analyses of expression levels of C-erbB-2, CXCR4, ER-a/β-actin (IOD) between pre- and post-therapy samples with western blotting

From: Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy

Parameters Pre-chemotherapy specimens Post-chemotherapy specimens Z p
C-erbB-2 0.546±0.182 0.442±0.142 -3.103 0.002
CXCR4 0.908±0.341 0.829±0.277 -2.689 0.002
ER-α 0.701±0.174 0.559±0.126 -3.516 0.00
  1. * p<0.05, compared with post-chemotherapy specimens